Half the participants had Parkinsons disease and half did not
While we are still waiting for large-scale clinical trials to confirm these effects, these early findings offer a promising new way to help calm the inflammatory environment in the body
When you buy NAD+ in the UK from Peptides Lab UK, you receive: 99% purity, HPLC and MS verified, third-party tested Full COA documentation per batch Fast same-day UK dispatch with tracked delivery Competitive pricing with bulk research discounts available Trusted by researchers across the UK and Europe Research Disclaimer: All products supplied by Peptides Lab UK are intended strictly for in-vitro laboratory research and scientific study use only
Xu X, Gao W, Cheng S, Yin D, Li F, Wu Y, et al
Cancer Res 38, 2003010
BOTTOM LINE My view is that semaglutide will be an increasingly popular option for MASH, it has a well understood side effect profile, is 'relatively' inexpensive and has a bucket load of RWD and support behind it